Ibrutinib for Chronic Lymphocytic Leukemia.
Shaare Zedek Medical Center, Jerusalem, Israel.
Rosa
R
Ruchlemer
Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Ronen
R
Ben Ami
Shaare Zedek Medical Center, Jerusalem, Israel ruc@szmc.org.il.
Tamar
T
Lachish
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002699:Chlorambucil / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D008297:Male; D011720:Pyrazoles / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D011720:Pyrazoles; D011743:Pyrimidines; D002699:Chlorambucil